Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP11-762I7.5 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | CDRT15L2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | C19orf45 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | ETHE1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | KIR2DL3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | IL17D | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | JARID2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | RECK | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | ITSN2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
mRNA | MISP | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |